Physician profile
Albert W Harrison
NPI 1306285465
$51,665.51
in general payments reported to CMS, 2019-2025
13 companies · $25K in 2025
The $25K reported for 2025 was more than what 95% of Vascular Surgery providers received nationally (typical 2025 total: $927).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,515 · 2020: $560 · 2021: $980 · 2022: $2,640 · 2023: $11K · 2024: $11K · 2025: $25K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Long Term Medical Supply Or Device Loan: $44K · Food and Beverage: $2,137.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Long Term Medical Supply Or Device Loan | $43,833.33 |
| Food and Beverage | $2,137.29 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Angiodynamics, INC. | $46,606.91 | 2022-2025 | Auryon Laser System 100-120 Vac, Auryon Laser System 100-120 Vac |
| W. L. Gore & Associates, INC. | $2,299.01 | 2019-2025 | Excluder Conformable Aaa Endoprosthesis With Active Control, Gore Viabahn Vbx Balloon Expandable Endo |
| Bolton Medical INC | $1,859.02 | 2020-2025 | Treo Abdominal Stent-Graft System, Relay Thoracic Stent-Graft With Plus Delivery System |
| Medtronic, INC. | $227.19 | 2021-2023 | Endurant Iis |
| Baxter Healthcare | $181.02 | 2021-2022 | |
| Lemaitre Vascular, INC. | $134.54 | 2023-2025 | Artegraft Vascular Graft, Xenosure Biologic Patch, Anastoclip Gc 8cm (Medium) |
| Boston Scientific Corporation | $96.45 | 2021-2025 | Varithena Administration Pack |
| Bard Peripheral Vascular, INC. | $90.18 | 2019 | |
| Medtronic Vascular, INC. | $87.21 | 2020 | |
| Smith+Nephew, INC. | $35.67 | 2021-2025 | Pico 14, "Acticoat 4"" X 4""", Pico 7 |
| Cardiovascular Systems INC. | $19.88 | 2022 | |
| Philips North America LLC | $14.75 | 2020 | |
| Baudax Bio INC. | $13.68 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Albert Harrison listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.